WE
William E. Rote
DELAYED 1 MONTH
Chief Research Officer
Travere Therapeutics, Inc.
Filings
1
Companies
1
Latest
May 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
58
TVTXCLUSTER 8
Travere Therapeutics, Inc.
William E. Rote
Chief Research Officer
Sale
$121.4K
2,763 sh
May 7 12:00 AM
May 6, 2026
—
Travere Therapeutics, Inc.
William E. Rote
Chief Research Officer
Option Exercise
—
4,250 sh
May 7 12:00 AM
May 4, 2026